1Neurovascular unit on a chip:the relevance and maturity as an advanced in vitro modelSujey Palma-Florez，Anna Lagunas，Mònica MirPerspectives1165-1166
2Does astrocytic L-lactate enhance cognition through myelination?Mastura Akter，Ying LiPerspectives1167-1168
3CRABP1-mediated non-canonical retinoic acid signaling in motor neurons and neural stem cellsLi-Na WeiPerspectives1169-1170
5The immune system:uncharted pathways between senses and the brainNoelia Casares，Mar Cuadrado-Tejedor，Ana García-Osta，Juan José LasartePerspectives1173-1174
6Dual PPAR delta/gamma agonists offer therapeutic potential for Alzheimer's diseaseIan Steinke，Meenakshi Singh，Rajesh AminPerspectives1175-1176
7Anoctamin 4 defines glucose-inhibited neurons in the ventromedial hypothalamusLonglong Tu，Yanlin He，Yong XuPerspectives1177-1178
8Imaging mass spectrometry:a molecular microscope for studying the role of lipids in Parkinson's diseaseVinata Vedam-Mai，Jacob M.Samuel，Boone M.PrenticePerspectives1179-1180
9Aggresome-aggrephagy transition process:getting closer to the functional roles of HDAC6 and BAG3Hagen Körschgen，Christian BehlPerspectives1181-1182
10Metabolites and micronutrition in modulating amyotrophic lateral sclerosisKaterina Claud，Jun SunPerspectives1183-1184
11Smart electrochemical sensing of amyloid-beta to manage total Alzheimer's diseasesAjeet KaushikPerspectives1185-1186
12Insights on ZEB1-AS1:emerging roles from cancer to neurodegenerationStephana Carelli，Federica Rey，Erika Maghraby，Cristina CeredaPerspectives1187-1188
13Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetesCarmen Hierro-Bujalance，Monica Garcia-AllozaPerspectives1189-1190
14Potential role of tubulin glutamylation in neurodegenerative diseasesAbdullah Md.Sheikh，Shatera TabassumPerspectives1191-1192
15Hippocampal dopamine as a key regulator for learning deficits in Parkinson's diseaseKun Wu，Shuai LiuPerspectives1193-1194
16Nuance of inward rectifying potassium(Kir)channel dysfunctions in neurodegenerative diseasesBenjamin Garland，Linlin MaPerspectives1195-1196
17Influence of aging,mitochondrial dysfunction,and inflammation on Parkinson's diseaseDavide Cossu，Nobutaka HattoriPerspectives1197-1198
18Investigating epithelial-neuronal signaling contribution in visceral pain through colon organoid-dorsal root ganglion neuron co-culturesFrancesco Margiotta，Lorenzo Di Cesare Mannelli，Antonino Morabito，Carla Ghelardini，Elena LucariniPerspectives1199-1200
19SCFD1 in amyotrophic lateral sclerosis:reconciling a genetic association with in vivo functional analysisRuben J.CauchiPerspectives1201-1202
20Neural plasticity in Parkinson's disease:a neuroimaging perspectiveChristina Andica，Koji KamagataPerspectives1203-1205
